A newly identified RNA target could make EGFR drugs work better against glioblastoma

Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
ascopubs.org

Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation ...

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and ...
Hospital Healthcare Europe

EGFR-linked immune pathway amplifying allergic inflammation in asthma identified

A hormone-related interleukin (IL)–epidermal growth factor receptor (EGFR) axis that underpins greater type 2 (T2) ...
ascopubs.org

EGFR variant III expression in Chinese patients with non-small cell lung cancer.

Frequency and clinical correlations of epidermal growth factor receptor (EGFR) mutations in a large cohort of Italian non-small cell lung cancer (NSCLC) patients (pts) within the EGFR FASTnet program.

ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

Detailed price information for Arrivent Biopharma Inc (AVBP-Q) from The Globe and Mail including charting and trades.
EurekAlert!

Unmasking a hidden driver of glioma: CHKA teams up with EGFR to ignite the MAPK pathway

Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline ...